- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.04. | SEP Acquisition Extends Termination Date on Shareholder-Approved SANUWAVE Deal | 1 | The SPAC Conference | ||
| 26.04. | SANUWAVE Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.04. | SANUWAVE Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.04. | SANUWAVE Health, Inc.: SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024) | 42 | GlobeNewswire (Europe) | SANUWAVE is pleased to announce preliminary revenues of $5.7 million to $5.9 million for the first quarter ended March 31, 2024. This represents the highest Q1 revenues in company history. Q1 2024... ► Artikel lesen | |
| 01.04. | SANUWAVE Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.04. | SANUWAVE Health, Inc.: SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer | 45 | GlobeNewswire (Europe) |
Sorensen brings strong finance, forecasting, analysis, and capital markets experience as well as abilities in software, process automation, and human resources to SANUWAVE EDEN PRAIRIE, MN, April... ► Artikel lesen | |
| 25.03. | SANUWAVE Health, Inc. (PNK:SNWV) Q4 2023 Earnings Call Transcript | 1 | Insider Monkey | ||
| 22.03. | SANUWAVE Health reports Q4 results | 2 | Seeking Alpha | ||
| 22.03. | SANUWAVE Health, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 22.03. | SANUWAVE Health, Inc.: SANUWAVE Announces Record Q4 and FY2023 Revenue | 1 | GlobeNewswire (USA) | ||
| 21.03. | SANUWAVE Health, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 07.03. | SANUWAVE Health, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 23.02. | SANUWAVE Health Stockholders Approve SPAC Merger | 1 | The SPAC Conference | ||
| 22.02. | SANUWAVE Health, Inc.: SANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of Stockholders | 214 | GlobeNewswire (Europe) | At a special meeting of stockholders on February 21, 2024, SANUWAVE stockholders approved the business combination with SEP Acquisition Corp. by a vote of 798,379,869 "for" and 5,221,765 "against"... ► Artikel lesen | |
| 21.02. | SANUWAVE Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 02.02. | SEP Acquisition shareholders approve Sanuwave SPAC merger | 1 | Seeking Alpha | ||
| 31.01. | SEP Acquisition Shareholders Approve SANUWAVE Deal | 1 | The SPAC Conference | ||
| 25.01. | SANUWAVE Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22.01. | SANUWAVE Health Slates Vote on SEP Acquisition Deal | 1 | The SPAC Conference | ||
| 10.01. | Sanuwave Health sees Q4 record revenue $6.6M-$6.8M, up 20% Y/Y | 1 | Seeking Alpha |
Seite:
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 51,90 | +1,37 % | Siemens Healthineers: Aktie klettert im DAX - das beflügelt | Die Aktie von Siemens Healthineers sichert sich am Montag einen der Spitzenränge im DAX. Auftrieb verleihen positive News vom Konkurrenten Philips. Dessen Aktie zieht mittlerweile mit einem Plus von... ► Artikel lesen | |
| FRESENIUS | 27,950 | -0,07 % | Fresenius mit Verkauf: Wachstum des Kerngeschäfts im Fokus - Aktie zieht weiter an | Fresenius kommt bei seiner Neuausrichtung weiter voran. Wie der Gesundheitskonzern am Donnerstagabend mitgeteilt hat, soll das Vamed-Reha-Geschäft veräußert werden. Fresenius werde aber ein Drittel... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,260 | -2,34 % | Kursgewinne für die Aktie von Fresenius Medical Care (38,13 €) | Im deutschen Wertpapierhandel liegt der Anteilsschein von Fresenius Medical Care aktuell im Plus. Das Wertpapier kostete zuletzt 38,13 Euro. Freuen können sich gegenwärtig die Aktionäre von Fresenius... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 64,31 | +4,16 % | PROCEPT BioRobotics Corp - 10-Q, Quarterly Report | ||
| CARL ZEISS MEDITEC | 97,80 | +0,46 % | Neue 11,00% Aktienanleihe mit Barriere auf Carl Zeiss Meditec in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VD4NFC9/ WKN VD4NFC) mit Barriere auf die Aktie von Carl Zeiss... ► Artikel lesen | |
| MOBILE-HEALTH NETWORK SOLUTIONS | 3,330 | -84,91 % | Mobile-health Retreats on Opening New Pharmacy | ||
| RXSIGHT | 61,68 | +3,44 % | RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | ALISO VIEJO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
| ATRICURE | 20,890 | -5,99 % | AtriCure Reports First Quarter 2024 Financial Results | MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and... ► Artikel lesen | |
| GERRESHEIMER | 102,00 | +0,39 % | EQS-News: Gerresheimer AG: Gerresheimer schließt Partnerschaft mit RxCap für vernetzte Adhärenz-Lösungen | EQS-News: Gerresheimer AG
/ Schlagwort(e): Vertrag/Beteiligung/Unternehmensbeteiligung
Gerresheimer schließt Partnerschaft mit RxCap für vernetzte Adhärenz-Lösungen
29.04.2024... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 18,740 | +1,79 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results | Achieved All 2023 Operating and Financial Guidance MetricsImplemented Providers +19.4% compared to Year-End 2022Introduces Full-Year 2024 GuidanceProactive Steps to Limit Downside Risk Arrangements... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 11,500 | +3,98 % | BrightSpring Health Services, Inc. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Guidance | LOUISVILLE, Ky., May 02, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| CASTLE BIOSCIENCES | 24,330 | +6,52 % | Castle Biosciences Reports First Quarter 2024 Results | FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results... ► Artikel lesen | |
| ADAPTHEALTH | 10,260 | -0,87 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 6,630 | +26,05 % | Alignment Healthcare Reports First Quarter 2024 Results | Reports $628.6 million in total revenue and $627.6 million in revenue excluding ACO REACH, up 43.1% and 54.2% year-over-year respectivelyMedicare Advantage membership grows 50.5% year-over-year to... ► Artikel lesen | |
| MIMEDX | 7,370 | -1,73 % | MiMedx Group, Inc: MIMEDX Announces First Quarter 2024 Operating and Financial Results | Net Sales of $85 Million Grew 18% Year-Over-Year for the First Quarter First Quarter GAAP Net Income was $9 Million First Quarter Adjusted EBITDA of $19 Million, or 22% of Net Sales Management... ► Artikel lesen |
Das Unternehmen SANUWAVE HEALTH INC kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
